nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—MAOB—autistic disorder	0.341	0.465	CbGaD
Methamphetamine—MAOA—autistic disorder	0.239	0.326	CbGaD
Methamphetamine—SLC6A4—autistic disorder	0.154	0.21	CbGaD
Methamphetamine—SLC18A2—telencephalic ventricle—autistic disorder	0.00559	0.0683	CbGeAlD
Methamphetamine—SLC6A3—telencephalic ventricle—autistic disorder	0.00423	0.0517	CbGeAlD
Methamphetamine—SLC18A1—head—autistic disorder	0.00262	0.032	CbGeAlD
Methamphetamine—SLC18A1—nervous system—autistic disorder	0.00248	0.0303	CbGeAlD
Methamphetamine—SLC18A1—central nervous system—autistic disorder	0.00239	0.0292	CbGeAlD
Methamphetamine—TAAR1—nervous system—autistic disorder	0.00233	0.0285	CbGeAlD
Methamphetamine—TAAR1—central nervous system—autistic disorder	0.00225	0.0274	CbGeAlD
Methamphetamine—SLC6A3—hindbrain—autistic disorder	0.002	0.0244	CbGeAlD
Methamphetamine—SLC18A1—brain—autistic disorder	0.0019	0.0232	CbGeAlD
Methamphetamine—SLC6A4—hindbrain—autistic disorder	0.00183	0.0224	CbGeAlD
Methamphetamine—MAOB—hindbrain—autistic disorder	0.00174	0.0213	CbGeAlD
Methamphetamine—SLC22A3—mouth—autistic disorder	0.00165	0.0201	CbGeAlD
Methamphetamine—SLC18A2—brainstem—autistic disorder	0.00151	0.0185	CbGeAlD
Methamphetamine—MAOA—hindbrain—autistic disorder	0.00148	0.0181	CbGeAlD
Methamphetamine—SLC18A2—forebrain—autistic disorder	0.00146	0.0178	CbGeAlD
Methamphetamine—SLC18A2—telencephalon—autistic disorder	0.00134	0.0164	CbGeAlD
Methamphetamine—SLC6A3—brainstem—autistic disorder	0.00114	0.014	CbGeAlD
Methamphetamine—SLC6A3—forebrain—autistic disorder	0.0011	0.0135	CbGeAlD
Methamphetamine—SLC6A4—brainstem—autistic disorder	0.00105	0.0128	CbGeAlD
Methamphetamine—SLC18A2—digestive system—autistic disorder	0.00103	0.0125	CbGeAlD
Methamphetamine—SLC6A3—telencephalon—autistic disorder	0.00102	0.0124	CbGeAlD
Methamphetamine—SLC6A4—forebrain—autistic disorder	0.00101	0.0124	CbGeAlD
Methamphetamine—MAOB—brainstem—autistic disorder	0.000997	0.0122	CbGeAlD
Methamphetamine—MAOB—forebrain—autistic disorder	0.000963	0.0118	CbGeAlD
Methamphetamine—SLC6A4—telencephalon—autistic disorder	0.000931	0.0114	CbGeAlD
Methamphetamine—SLC6A2—brainstem—autistic disorder	0.000924	0.0113	CbGeAlD
Methamphetamine—SLC6A2—forebrain—autistic disorder	0.000891	0.0109	CbGeAlD
Methamphetamine—MAOB—telencephalon—autistic disorder	0.000885	0.0108	CbGeAlD
Methamphetamine—CYP2D6—hindbrain—autistic disorder	0.000882	0.0108	CbGeAlD
Methamphetamine—MAOA—brainstem—autistic disorder	0.000851	0.0104	CbGeAlD
Methamphetamine—Isocarboxazid—MAOB—autistic disorder	0.000851	0.126	CrCbGaD
Methamphetamine—SLC18A2—head—autistic disorder	0.000836	0.0102	CbGeAlD
Methamphetamine—MAOA—forebrain—autistic disorder	0.000821	0.01	CbGeAlD
Methamphetamine—SLC6A2—telencephalon—autistic disorder	0.00082	0.01	CbGeAlD
Methamphetamine—SLC18A2—nervous system—autistic disorder	0.000793	0.00968	CbGeAlD
Methamphetamine—SLC18A2—central nervous system—autistic disorder	0.000763	0.00932	CbGeAlD
Methamphetamine—MAOA—telencephalon—autistic disorder	0.000755	0.00922	CbGeAlD
Methamphetamine—SLC18A2—cerebellum—autistic disorder	0.000746	0.00911	CbGeAlD
Methamphetamine—ADRA2C—telencephalon—autistic disorder	0.000726	0.00887	CbGeAlD
Methamphetamine—SLC6A4—digestive system—autistic disorder	0.000711	0.00868	CbGeAlD
Methamphetamine—MAOB—digestive system—autistic disorder	0.000676	0.00825	CbGeAlD
Methamphetamine—SLC6A3—head—autistic disorder	0.000633	0.00773	CbGeAlD
Methamphetamine—ADRA2A—forebrain—autistic disorder	0.00063	0.00769	CbGeAlD
Methamphetamine—SLC18A2—brain—autistic disorder	0.000606	0.0074	CbGeAlD
Methamphetamine—SLC6A3—nervous system—autistic disorder	0.0006	0.00732	CbGeAlD
Methamphetamine—Isocarboxazid—MAOA—autistic disorder	0.000597	0.0885	CrCbGaD
Methamphetamine—SLC22A3—head—autistic disorder	0.000596	0.00727	CbGeAlD
Methamphetamine—SLC6A4—head—autistic disorder	0.00058	0.00708	CbGeAlD
Methamphetamine—ADRA2A—telencephalon—autistic disorder	0.000579	0.00708	CbGeAlD
Methamphetamine—SLC6A3—central nervous system—autistic disorder	0.000578	0.00705	CbGeAlD
Methamphetamine—MAOA—digestive system—autistic disorder	0.000577	0.00704	CbGeAlD
Methamphetamine—SLC22A3—nervous system—autistic disorder	0.000565	0.0069	CbGeAlD
Methamphetamine—SLC6A3—cerebellum—autistic disorder	0.000564	0.00689	CbGeAlD
Methamphetamine—MAOB—head—autistic disorder	0.000551	0.00673	CbGeAlD
Methamphetamine—SLC6A4—nervous system—autistic disorder	0.00055	0.00671	CbGeAlD
Methamphetamine—Pargyline—MAOB—autistic disorder	0.000548	0.0813	CrCbGaD
Methamphetamine—SLC22A3—central nervous system—autistic disorder	0.000544	0.00664	CbGeAlD
Methamphetamine—SLC22A5—digestive system—autistic disorder	0.000531	0.00648	CbGeAlD
Methamphetamine—SLC6A4—central nervous system—autistic disorder	0.000529	0.00646	CbGeAlD
Methamphetamine—MAOB—nervous system—autistic disorder	0.000523	0.00638	CbGeAlD
Methamphetamine—Phenelzine—ABAT—autistic disorder	0.000515	0.0765	CrCbGaD
Methamphetamine—SLC6A2—head—autistic disorder	0.00051	0.00623	CbGeAlD
Methamphetamine—CYP2D6—brainstem—autistic disorder	0.000506	0.00618	CbGeAlD
Methamphetamine—MAOB—central nervous system—autistic disorder	0.000503	0.00614	CbGeAlD
Methamphetamine—MAOB—cerebellum—autistic disorder	0.000492	0.00601	CbGeAlD
Methamphetamine—CYP2D6—forebrain—autistic disorder	0.000488	0.00596	CbGeAlD
Methamphetamine—SLC6A2—nervous system—autistic disorder	0.000484	0.00591	CbGeAlD
Methamphetamine—MAOA—head—autistic disorder	0.00047	0.00574	CbGeAlD
Methamphetamine—Pseudoephedrine—IL2—autistic disorder	0.000467	0.0693	CrCbGaD
Methamphetamine—SLC6A2—central nervous system—autistic disorder	0.000466	0.00569	CbGeAlD
Methamphetamine—SLC6A3—brain—autistic disorder	0.000458	0.0056	CbGeAlD
Methamphetamine—ADRA2C—head—autistic disorder	0.000452	0.00552	CbGeAlD
Methamphetamine—CYP2D6—telencephalon—autistic disorder	0.000449	0.00548	CbGeAlD
Methamphetamine—MAOA—nervous system—autistic disorder	0.000446	0.00544	CbGeAlD
Methamphetamine—SLC22A3—brain—autistic disorder	0.000432	0.00527	CbGeAlD
Methamphetamine—MAOA—central nervous system—autistic disorder	0.000429	0.00524	CbGeAlD
Methamphetamine—ADRA2C—nervous system—autistic disorder	0.000429	0.00523	CbGeAlD
Methamphetamine—SLC6A4—brain—autistic disorder	0.00042	0.00513	CbGeAlD
Methamphetamine—MAOA—cerebellum—autistic disorder	0.00042	0.00512	CbGeAlD
Methamphetamine—ADRA2C—central nervous system—autistic disorder	0.000413	0.00504	CbGeAlD
Methamphetamine—ADRA2C—cerebellum—autistic disorder	0.000403	0.00493	CbGeAlD
Methamphetamine—MAOB—brain—autistic disorder	0.000399	0.00488	CbGeAlD
Methamphetamine—SLC22A5—cerebellum—autistic disorder	0.000386	0.00472	CbGeAlD
Methamphetamine—Pargyline—MAOA—autistic disorder	0.000384	0.057	CrCbGaD
Methamphetamine—SLC6A2—brain—autistic disorder	0.00037	0.00452	CbGeAlD
Methamphetamine—ADRA2A—head—autistic disorder	0.000361	0.00441	CbGeAlD
Methamphetamine—CYP2D6—digestive system—autistic disorder	0.000343	0.00418	CbGeAlD
Methamphetamine—ADRA2A—nervous system—autistic disorder	0.000342	0.00418	CbGeAlD
Methamphetamine—MAOA—brain—autistic disorder	0.000341	0.00416	CbGeAlD
Methamphetamine—ADRA2A—central nervous system—autistic disorder	0.000329	0.00402	CbGeAlD
Methamphetamine—ADRA2C—brain—autistic disorder	0.000328	0.004	CbGeAlD
Methamphetamine—ADRA2A—cerebellum—autistic disorder	0.000322	0.00393	CbGeAlD
Methamphetamine—SLC22A5—brain—autistic disorder	0.000314	0.00383	CbGeAlD
Methamphetamine—Phentermine—MAOB—autistic disorder	0.000296	0.0439	CrCbGaD
Methamphetamine—CYP2D6—head—autistic disorder	0.000279	0.00341	CbGeAlD
Methamphetamine—Dexfenfluramine—SLC6A4—autistic disorder	0.000278	0.0412	CrCbGaD
Methamphetamine—Selegiline—MAOB—autistic disorder	0.000274	0.0406	CrCbGaD
Methamphetamine—CYP2D6—nervous system—autistic disorder	0.000265	0.00324	CbGeAlD
Methamphetamine—ADRA2A—brain—autistic disorder	0.000261	0.00319	CbGeAlD
Methamphetamine—CYP2D6—central nervous system—autistic disorder	0.000255	0.00312	CbGeAlD
Methamphetamine—CYP2D6—cerebellum—autistic disorder	0.000249	0.00304	CbGeAlD
Methamphetamine—Phenelzine—MAOB—autistic disorder	0.000241	0.0358	CrCbGaD
Methamphetamine—Phenylpropanolamine—MAOA—autistic disorder	0.000233	0.0345	CrCbGaD
Methamphetamine—Amphetamine—MAOB—autistic disorder	0.000228	0.0338	CrCbGaD
Methamphetamine—Phenylpropanolamine—DRD1—autistic disorder	0.000212	0.0314	CrCbGaD
Methamphetamine—Phentermine—MAOA—autistic disorder	0.000208	0.0308	CrCbGaD
Methamphetamine—CYP2D6—brain—autistic disorder	0.000203	0.00247	CbGeAlD
Methamphetamine—Pseudoephedrine—MAOA—autistic disorder	0.000197	0.0292	CrCbGaD
Methamphetamine—Selegiline—MAOA—autistic disorder	0.000192	0.0285	CrCbGaD
Methamphetamine—Ephedrine—ADRB2—autistic disorder	0.000184	0.0273	CrCbGaD
Methamphetamine—Phenelzine—MAOA—autistic disorder	0.000169	0.0251	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRB2—autistic disorder	0.000165	0.0245	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRB2—autistic disorder	0.00014	0.0207	CrCbGaD
Methamphetamine—Phentermine—SLC6A4—autistic disorder	0.000134	0.0199	CrCbGaD
Methamphetamine—Pseudoephedrine—SLC6A4—autistic disorder	0.000127	0.0188	CrCbGaD
Methamphetamine—Amphetamine—SLC6A4—autistic disorder	0.000103	0.0153	CrCbGaD
Methamphetamine—ADRA2A—Hemostasis—PIK3CG—autistic disorder	1.02e-05	5.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—HTR2A—autistic disorder	1.01e-05	5.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—EGF—autistic disorder	1.01e-05	5.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TPH2—autistic disorder	1e-05	5.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—OPRM1—autistic disorder	1e-05	5.65e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—MTHFR—autistic disorder	9.91e-06	5.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—DPYD—autistic disorder	9.87e-06	5.58e-05	CbGpPWpGaD
Methamphetamine—SLC6A3—Neuronal System—HRAS—autistic disorder	9.85e-06	5.57e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PIK3CG—autistic disorder	9.84e-06	5.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—ADRB2—autistic disorder	9.81e-06	5.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—GZMB—autistic disorder	9.79e-06	5.53e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CYP19A1—autistic disorder	9.78e-06	5.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AVPR1A—autistic disorder	9.74e-06	5.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PLA2G4A—autistic disorder	9.68e-06	5.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR1B—autistic disorder	9.5e-06	5.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—OXT—autistic disorder	9.5e-06	5.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—IL2—autistic disorder	9.44e-06	5.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—HTR2A—autistic disorder	9.44e-06	5.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VIP—autistic disorder	9.41e-06	5.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GRM5—autistic disorder	9.41e-06	5.32e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—POMC—autistic disorder	9.37e-06	5.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IGF1—autistic disorder	9.32e-06	5.27e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADSL—autistic disorder	9.28e-06	5.24e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—APOE—autistic disorder	9.23e-06	5.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AVP—autistic disorder	9.21e-06	5.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HTR2A—autistic disorder	9.18e-06	5.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CACNA1C—autistic disorder	9.17e-06	5.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—GZMB—autistic disorder	9.15e-06	5.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—OXTR—autistic disorder	9.11e-06	5.15e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—XDH—autistic disorder	9.1e-06	5.14e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—COMT—autistic disorder	9.09e-06	5.14e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GSTP1—autistic disorder	9.05e-06	5.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SCT—autistic disorder	9.02e-06	5.1e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NPAS2—autistic disorder	8.93e-06	5.05e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—STX1A—autistic disorder	8.93e-06	5.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—ADRB2—autistic disorder	8.91e-06	5.03e-05	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—MAPK1—autistic disorder	8.9e-06	5.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR1B—autistic disorder	8.88e-06	5.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—OXT—autistic disorder	8.88e-06	5.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PRKCB—autistic disorder	8.86e-06	5.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—SERPINE1—autistic disorder	8.85e-06	5e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TSC1—autistic disorder	8.84e-06	5e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—DRD1—autistic disorder	8.84e-06	5e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—IL2—autistic disorder	8.82e-06	4.99e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CAT—autistic disorder	8.81e-06	4.98e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TCN2—autistic disorder	8.62e-06	4.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GABBR1—autistic disorder	8.61e-06	4.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADM—autistic disorder	8.61e-06	4.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NTRK2—autistic disorder	8.6e-06	4.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2A—autistic disorder	8.57e-06	4.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—DRD3—autistic disorder	8.56e-06	4.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CG—autistic disorder	8.48e-06	4.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EIF4E—autistic disorder	8.46e-06	4.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PDE4B—autistic disorder	8.39e-06	4.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL5—autistic disorder	8.38e-06	4.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AVP—autistic disorder	8.37e-06	4.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—DHFR—autistic disorder	8.35e-06	4.72e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CG—autistic disorder	8.33e-06	4.71e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PLA2G4A—autistic disorder	8.32e-06	4.7e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GSTM1—autistic disorder	8.32e-06	4.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PRKCB—autistic disorder	8.27e-06	4.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CALCA—autistic disorder	8.27e-06	4.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TSC1—autistic disorder	8.25e-06	4.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—DRD1—autistic disorder	8.25e-06	4.67e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADA—autistic disorder	8.23e-06	4.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—OPRM1—autistic disorder	8.12e-06	4.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—POMC—autistic disorder	8.07e-06	4.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CYP19A1—autistic disorder	8.05e-06	4.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PRKCB—autistic disorder	8.04e-06	4.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NTRK2—autistic disorder	8.03e-06	4.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—DRD3—autistic disorder	7.99e-06	4.52e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GPX1—autistic disorder	7.97e-06	4.5e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—POMC—autistic disorder	7.93e-06	4.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CG—autistic disorder	7.92e-06	4.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PLA2G4A—autistic disorder	7.87e-06	4.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL5—autistic disorder	7.82e-06	4.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CALCA—autistic disorder	7.73e-06	4.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CG—autistic disorder	7.7e-06	4.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2A—autistic disorder	7.67e-06	4.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—POMC—autistic disorder	7.54e-06	4.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PRKCB—autistic disorder	7.51e-06	4.25e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—RORA—autistic disorder	7.5e-06	4.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—COMT—autistic disorder	7.48e-06	4.23e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—autistic disorder	7.47e-06	4.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTP1—autistic disorder	7.45e-06	4.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—GZMB—autistic disorder	7.43e-06	4.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MAOA—autistic disorder	7.43e-06	4.2e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—MTHFR—autistic disorder	7.35e-06	4.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—POMC—autistic disorder	7.33e-06	4.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRL—autistic disorder	7.31e-06	4.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAT—autistic disorder	7.25e-06	4.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—MAPK1—autistic disorder	7.22e-06	4.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR1B—autistic disorder	7.21e-06	4.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—OXT—autistic disorder	7.21e-06	4.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CG—autistic disorder	7.19e-06	4.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—IL2—autistic disorder	7.16e-06	4.05e-05	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—autistic disorder	7.14e-06	4.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MAOB—autistic disorder	7.03e-06	3.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2A—autistic disorder	6.96e-06	3.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRB2—autistic disorder	6.93e-06	3.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—POMC—autistic disorder	6.85e-06	3.87e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—APOE—autistic disorder	6.84e-06	3.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTM1—autistic disorder	6.84e-06	3.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PLA2G4A—autistic disorder	6.84e-06	3.87e-05	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—autistic disorder	6.84e-06	3.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRL—autistic disorder	6.83e-06	3.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—MAPK1—autistic disorder	6.75e-06	3.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PRKCB—autistic disorder	6.72e-06	3.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TSC1—autistic disorder	6.7e-06	3.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—DRD1—autistic disorder	6.7e-06	3.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GPX1—autistic disorder	6.55e-06	3.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP19A1—autistic disorder	6.54e-06	3.7e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TPH2—autistic disorder	6.54e-06	3.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NTRK2—autistic disorder	6.52e-06	3.69e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTEN—autistic disorder	6.52e-06	3.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AVP—autistic disorder	6.51e-06	3.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—DRD3—autistic disorder	6.49e-06	3.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF2—autistic disorder	6.49e-06	3.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRB2—autistic disorder	6.48e-06	3.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CG—autistic disorder	6.43e-06	3.64e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—DPYD—autistic disorder	6.43e-06	3.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL5—autistic disorder	6.36e-06	3.59e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—autistic disorder	6.32e-06	3.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CALCA—autistic disorder	6.28e-06	3.55e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CG—autistic disorder	6.18e-06	3.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PLA2G4A—autistic disorder	6.12e-06	3.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—POMC—autistic disorder	6.12e-06	3.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PRKCB—autistic disorder	6.1e-06	3.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AVP—autistic disorder	6.09e-06	3.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—COMT—autistic disorder	6.08e-06	3.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF2—autistic disorder	6.06e-06	3.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTP1—autistic disorder	6.05e-06	3.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MTHFR—autistic disorder	6.05e-06	3.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MAOA—autistic disorder	6.03e-06	3.41e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CACNA1C—autistic disorder	5.98e-06	3.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—IL2—autistic disorder	5.97e-06	3.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MEF2C—autistic disorder	5.96e-06	3.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAT—autistic disorder	5.88e-06	3.33e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—POMC—autistic disorder	5.88e-06	3.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CG—autistic disorder	5.84e-06	3.3e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ITGB3—autistic disorder	5.81e-06	3.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—autistic disorder	5.8e-06	3.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PLA2G4A—autistic disorder	5.72e-06	3.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—APOE—autistic disorder	5.63e-06	3.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—IL2—autistic disorder	5.57e-06	3.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MEF2C—autistic disorder	5.57e-06	3.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—autistic disorder	5.56e-06	3.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PLA2G4A—autistic disorder	5.56e-06	3.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTM1—autistic disorder	5.56e-06	3.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRL—autistic disorder	5.55e-06	3.13e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTEN—autistic disorder	5.51e-06	3.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—MAPK1—autistic disorder	5.48e-06	3.1e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—DHFR—autistic disorder	5.44e-06	3.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ITGB3—autistic disorder	5.42e-06	3.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2A—autistic disorder	5.42e-06	3.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL2—autistic disorder	5.42e-06	3.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—autistic disorder	5.42e-06	3.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GPX1—autistic disorder	5.32e-06	3.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB2—autistic disorder	5.26e-06	2.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TSC2—autistic disorder	5.15e-06	2.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CG—autistic disorder	5.08e-06	2.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—autistic disorder	5.06e-06	2.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL2—autistic disorder	5.06e-06	2.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—LEP—autistic disorder	5.04e-06	2.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOE—autistic disorder	5.04e-06	2.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AVP—autistic disorder	4.94e-06	2.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF2—autistic disorder	4.92e-06	2.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—autistic disorder	4.91e-06	2.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—autistic disorder	4.84e-06	2.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TSC2—autistic disorder	4.81e-06	2.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCB—autistic disorder	4.75e-06	2.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—LEP—autistic disorder	4.71e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOE—autistic disorder	4.71e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—autistic disorder	4.69e-06	2.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PLA2G4A—autistic disorder	4.65e-06	2.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOE—autistic disorder	4.57e-06	2.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APC—autistic disorder	4.55e-06	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CG—autistic disorder	4.55e-06	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—IL2—autistic disorder	4.53e-06	2.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MEF2C—autistic disorder	4.52e-06	2.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGF—autistic disorder	4.5e-06	2.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCB—autistic disorder	4.44e-06	2.51e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ITGB3—autistic disorder	4.41e-06	2.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—autistic disorder	4.4e-06	2.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—autistic disorder	4.33e-06	2.45e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP19A1—autistic disorder	4.26e-06	2.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APC—autistic disorder	4.25e-06	2.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CG—autistic disorder	4.25e-06	2.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGF—autistic disorder	4.2e-06	2.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IGF1—autistic disorder	4.16e-06	2.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—MAPK1—autistic disorder	4.14e-06	2.34e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CG—autistic disorder	4.13e-06	2.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	4.11e-06	2.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL2—autistic disorder	4.11e-06	2.32e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTEN—autistic disorder	4.09e-06	2.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—autistic disorder	4.04e-06	2.29e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—COMT—autistic disorder	3.96e-06	2.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SERPINE1—autistic disorder	3.95e-06	2.24e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTP1—autistic disorder	3.94e-06	2.23e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MAOA—autistic disorder	3.93e-06	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—autistic disorder	3.93e-06	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TSC2—autistic disorder	3.91e-06	2.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IGF1—autistic disorder	3.89e-06	2.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—MAPK1—autistic disorder	3.87e-06	2.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—autistic disorder	3.86e-06	2.18e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAT—autistic disorder	3.83e-06	2.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—LEP—autistic disorder	3.82e-06	2.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOE—autistic disorder	3.82e-06	2.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SERPINE1—autistic disorder	3.69e-06	2.09e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	3.62e-06	2.05e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTM1—autistic disorder	3.62e-06	2.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	3.61e-06	2.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GPX1—autistic disorder	3.47e-06	1.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APC—autistic disorder	3.45e-06	1.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	3.45e-06	1.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGF—autistic disorder	3.41e-06	1.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTEN—autistic disorder	3.36e-06	1.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—autistic disorder	3.33e-06	1.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—autistic disorder	3.28e-06	1.86e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—autistic disorder	3.2e-06	1.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL2—autistic disorder	3.2e-06	1.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—autistic disorder	3.18e-06	1.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IGF1—autistic disorder	3.16e-06	1.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	3.14e-06	1.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—autistic disorder	3.13e-06	1.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—autistic disorder	3.11e-06	1.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTEN—autistic disorder	3.01e-06	1.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	3e-06	1.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL2—autistic disorder	2.99e-06	1.69e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOE—autistic disorder	2.98e-06	1.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—autistic disorder	2.97e-06	1.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTEN—autistic disorder	2.81e-06	1.59e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTEN—autistic disorder	2.73e-06	1.54e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CG—autistic disorder	2.69e-06	1.52e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—autistic disorder	2.56e-06	1.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	2.52e-06	1.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK1—autistic disorder	2.45e-06	1.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL2—autistic disorder	2.43e-06	1.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—autistic disorder	2.42e-06	1.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK1—autistic disorder	2.29e-06	1.29e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTEN—autistic disorder	2.28e-06	1.29e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—autistic disorder	2.04e-06	1.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—autistic disorder	1.97e-06	1.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—autistic disorder	1.88e-06	1.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	1.86e-06	1.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—autistic disorder	1.84e-06	1.04e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTEN—autistic disorder	1.78e-06	1.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—autistic disorder	1.76e-06	9.93e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—autistic disorder	1.49e-06	8.43e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—autistic disorder	1.43e-06	8.07e-06	CbGpPWpGaD
